6400 Fannin Street, Suite 1900
Houston, TX, USA
832-888-8710
Weatherhead Urologic Research Foundation
Advancing the Future of
Urologic Medicine Through Research
Advancing the Future of
Urologic Medicine Through Research
What is the Weatherhead Urologic Research Foundation?
The Vanguard Urologic Research Foundation is a distinguished not-for-profit research organization dedicated to advancing the future of urologic medicine through groundbreaking clinical and translational research. Committed to transforming scientific discoveries into innovative, patient centered treatments, the Foundation serves as a driving force behind the development of next generation therapies that improve outcomes and enhance quality of life.
By fostering collaboration between leading physicians, researchers, and healthcare institutions, the Foundation supports evidence based innovations that shape the future of urologic care. Patients who choose a physician affiliated with the Vanguard Urologic Research Foundation benefit from a practice committed not only to today's highest standards of medicine, but also to tomorrow's medical breakthroughs.
The Vanguard Urologic Research Foundation is a distinguished not-for-profit research organization dedicated to advancing the future of urologic medicine through groundbreaking clinical and translational research. Committed to transforming scientific discoveries into innovative, patient centered treatments, the Foundation serves as a driving force behind the development of next generation therapies that improve outcomes and enhance quality of life.
By fostering collaboration between leading physicians, researchers, and healthcare institutions, the Foundation supports evidence based innovations that shape the future of urologic care. Patients who choose a physician affiliated with the Vanguard Urologic Research Foundation benefit from a practice committed not only to today's highest standards of medicine, but also to tomorrow's medical breakthroughs.
Areas of Research Excellence
Prostate Cancer – Advancing precision diagnostics, innovative treatment strategies, and long-term survivorship to improve outcomes for men at every stage of prostate cancer.
Benign Prostatic Diseases – Investigating cutting-edge therapies for benign prostatic hyperplasia (BPH) and other non-cancerous prostate conditions to reduce symptoms and preserve quality of life.
Urinary Incontinence – Developing advanced solutions that restore bladder control through innovative surgical techniques, minimally invasive therapies, and regenerative medicine.
Urinary Reconstruction – Pioneering reconstructive procedures and tissue-preserving approaches for patients with complex urinary tract disorders, trauma, congenital conditions, and post-cancer reconstruction.
At the Vanguard Urologic Research Foundation, research extends beyond the laboratory; it directly influences patient care. Every study reflects a commitment to clinical excellence, scientific integrity, and the continual pursuit of safer, more effective treatments. This dedication ensures that patients have access to the latest advances in urologic medicine while contributing to discoveries that will benefit future generations.
Prostate Cancer – Advancing precision diagnostics, innovative treatment strategies, and long-term survivorship to improve outcomes for men at every stage of prostate cancer.
Benign Prostatic Diseases – Investigating cutting-edge therapies for benign prostatic hyperplasia (BPH) and other non-cancerous prostate conditions to reduce symptoms and preserve quality of life.
Urinary Incontinence – Developing advanced solutions that restore bladder control through innovative surgical techniques, minimally invasive therapies, and regenerative medicine.
Urinary Reconstruction – Pioneering reconstructive procedures and tissue-preserving approaches for patients with complex urinary tract disorders, trauma, congenital conditions, and post-cancer reconstruction.
At the Vanguard Urologic Research Foundation, research extends beyond the laboratory; it directly influences patient care. Every study reflects a commitment to clinical excellence, scientific integrity, and the continual pursuit of safer, more effective treatments. This dedication ensures that patients have access to the latest advances in urologic medicine while contributing to discoveries that will benefit future generations.
Understanding Prostate Cancer
What You Need to Know About Prostate Cancer
Prostate cancer is one of the most common cancers affecting men, but when detected early, it is also one of the most treatable. At the Vanguard Urologic Research Foundation, our commitment to prostate cancer extends beyond treatment, we are dedicated to advancing research, improving early detection, and developing innovative therapies that lead to better patient outcomes.
Our research focuses on enhancing diagnostic precision, evaluating emerging technologies, refining minimally invasive treatments, and expanding access to evidence-based care. Through clinical and translational research, we help bridge scientific discovery with real-world patient care, ensuring today's innovations become tomorrow's standard of excellence.
Every patient deserves an individualized approach. By supporting research that emphasizes precision medicine and long-term quality of life, the Foundation is helping shape the future of prostate cancer diagnosis, treatment, and survivorship.
Prostate cancer is one of the most common cancers affecting men, but when detected early, it is also one of the most treatable. At the Vanguard Urologic Research Foundation, our commitment to prostate cancer extends beyond treatment, we are dedicated to advancing research, improving early detection, and developing innovative therapies that lead to better patient outcomes.
Our research focuses on enhancing diagnostic precision, evaluating emerging technologies, refining minimally invasive treatments, and expanding access to evidence-based care. Through clinical and translational research, we help bridge scientific discovery with real-world patient care, ensuring today's innovations become tomorrow's standard of excellence.
Every patient deserves an individualized approach. By supporting research that emphasizes precision medicine and long-term quality of life, the Foundation is helping shape the future of prostate cancer diagnosis, treatment, and survivorship.
A Massive Piece of the Puzzle
Forty-two percent of all cancers in United States men are genitourinary in origin.
The Second Deadliest Male Cancer
Aside from skin cancer, prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths among American men.
Millions of Visits, Millions of Dollars
It is estimated that prostate cancer is the primary reason for 3 million outpatient visits per year and more than $900 million in medical care expenditures.
The Hidden Cost of Benign Conditions
Non-cancerous diseases of the prostate have an even greater impact, accounting for over 4 million physician visits and $100 million in Medicare expenditures per year.
Millions in Need of Relief
Urinary incontinence and urinary tract infections are even more common urologic diseases, leading to 1.7 million emergency room visits and over 10 million outpatient physician visits annually.
The $11 Billion Economic Burden
It is estimated that incontinence and urinary tract infections alone cost as much as $1.5 billion/year and that the total annual Medicare expenditure on urologic diseases is more than $11 billion /year.
At Vanguard Urological Institute
We Pride Ourselves On Providing:
Evidence-Based Care
Every treatment recommendation is guided by the latest clinical research, proven outcomes, and national standards of care.
Advanced Treatment Options
Access to innovative diagnostics and minimally invasive therapies tailored to each patient's needs.
We are committed to leading cutting-edge prostate cancer research & innovation – Dr. Tung Shu is dedicated to advancing the field of prostate cancer through active engagement in clinical and translational research, with a focus on improving early detection, refining precision diagnostics, and evaluating next-generation treatment strategies. His work emphasizes translating scientific discovery into real-world clinical impact, helping to elevate standards of care and expand options for patients at every stage of disease.
Comprehensive, Patient-Centered Prostate Cancer Care – Dr. Shu provides highly specialized, individualized care for patients facing prostate cancer, integrating advanced imaging, risk stratification, and evidence-based treatment planning. His approach prioritizes both oncologic excellence and quality of life, offering patients access to modern therapeutic pathways—including active surveillance, minimally invasive procedures, and multidisciplinary care coordination—tailored to each patient’s unique diagnosis and long-term goals.
Advanced Patient-Centered Care Process
Consult with Our Team
We carefully evaluate your medical history and current concerns.
Treatment Plan
Accurate diagnosis followed by a personalized treatment plan.
Minimally Invasive Care
Faster recovery with advanced treatment options.
Follow-up & Support
Ongoing follow-up to ensure long-term health improvement.
Patient Testimonials Healthier Happier Smiles
Discover real patient testimonials highlighting our expert medical care and personalized treatments, and compassionate support.
Vanguard FAQs – Everything Houston Need's to Know
Get answers to common questions, treatments & services for informed decision-making.
Do you offer private urology care in Houston?
Yes, our Houston clinic provides private, patient-focused urology care with personalized treatment plans, advanced diagnostics, and discreet consultations.
What conditions do you treat at your Houston urology clinic?
We treat a full range of urologic conditions including enlarged prostate (BPH), kidney stones, urinary tract infections (UTIs), erectile dysfunction (ED), and bladder control issues.
Do I need a referral to schedule an appointment?
For most PPO plans, no referral is required. Patients can directly schedule a private consultation with our Houston urology team for evaluation and treatment. For patients that have HMO plans, reach out to your PCP to request a referral.
What can I expect during my first visit?
Your first visit includes a comprehensive evaluation, review of symptoms, diagnostic testing if needed, and a personalized treatment plan tailored to your needs.
Vanguard Urology is committed to providing compassionate, continuous, and comprehensive healthcare.
Schedule Time
Mon - Thu: 8:00am - 5:00pm
Fri: 8:00am - 3:00pm
Address
6400 Fannin Street, Suite 1900, Houston, TX, USA
Phone: 832-888-8710
FAX: 832-520-2882
© Copyrights 2026. | Vanguard Urologic Institute. | All rights reserved.